---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-244283"
form_type: "8-K"
ticker: "VRCA"
cik: "0001660334"
company_name: "Verrica Pharmaceuticals Inc."
filed_at: "2022-09-14T23:59:59+00:00"
generated_at: "2026-06-23T09:44:09.486740+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Verrica posts updated corporate presentation; no material details provided in filing

## Summary
- Filing under Item 7.01 Regulation FD discloses updated corporate presentation posted on company website.
- Exhibit 99.1 consists only of a cover page; no specific financial or strategic updates are included in the filing.
- Presentation may contain operational updates, but content is not summarized in this 8-K.
- No changes to guidance, pipeline, or financials are explicitly stated.

## SEC filing metadata
- accession: 0001193125-22-244283
- form_type: 8-K
- ticker: VRCA
- cik: 0001660334
- company_name: Verrica Pharmaceuticals Inc.
- filed_at: 2022-09-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1660334/000119312522244283/0001193125-22-244283-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1660334/000119312522244283/d356833d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-244283
- JSON: https://secwatch.observer/filing/0001193125-22-244283.json
- Plain text: https://secwatch.observer/filing/0001193125-22-244283.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.